ABSTRACT:
This survey on pharmaceutical sales performance is well-founded, using a thorough methodology to gather data from various industry stakeholders. This includes pharmaceutical companies, healthcare providers, and other relevant parties. The goal is to provide valuable insights into the pharmaceutical market, helping to identify drugs in high or low demand. The analysis focuses on factors like effectiveness, marketing, pricing, and market dynamics, offering a deep understanding of what influences drug sales. The inclusion of diverse industry perspectives adds credibility, ensuring a well-rounded view. By examining individual drug categories and sales factors, the research provides a nuanced understanding of the market. Overall, the study aligns with best practices in pharmaceutical market research, making it valuable for understanding the dynamics of drug sales. It not only identifies trends but also provides practical insights for stakeholders to optimize their strategies in the evolving landscape of drug sales.
Cite this article:
Sucheta Thombare, Raj Nashikkar, Rajendra Patil, Shrikrishna Baokar. Market Dynamics: Examining Drug sales in Panvel. Asian Journal of Management. 2024;15(2):172-6. doi: 10.52711/2321-5763.2024.00027
Cite(Electronic):
Sucheta Thombare, Raj Nashikkar, Rajendra Patil, Shrikrishna Baokar. Market Dynamics: Examining Drug sales in Panvel. Asian Journal of Management. 2024;15(2):172-6. doi: 10.52711/2321-5763.2024.00027 Available on: https://ajmjournal.com/AbstractView.aspx?PID=2024-15-2-13
REFERENCE:
1. National Pharmaceuticals Pricing Policy, 2011 [Internet]. 2011. http://pharmaceuticals.gov.in/mshT2810/FTY2.pdf.
2. Gill J, Taylor D. Health and healthcare in India: national opportunities and global impact [Internet]. 2013. http://www.ucl.ac.uk/pharmacy/documents/news_docs/healthcareinindiajuly2013.
3. PricewaterhouseCoopers. Healthcare in India: emerging market report 2007 [Internet]. 2007. http://www.pwc.com/en_GX/gx/healthcare/pdf/emerging-market-report-hc-in-india.pdf.
4. National Commission on Macroeconomics and Health Ministry of Health & Family Welfare, Government of India. Report of the National Commission on Macroeconomics and Health [Internet]. New Delhi; 2005. http://www.who.int/macrohealth/action/Report of the National Commission.pdf.
5. Eaddy MT, Cook CL, O’Day K, et al. How patient cost-sharing trends affect adherence and outcomes: a literature review. P T [Internet]. 2012 (cited 2013 Oct 15); 37(1):45–55. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3278192&tool=pmcentrez&rendertype=abstract.
6. Martin LR, Williams SL, Haskard KB, Dimatteo MR. The challenge of patient adherence. Ther Clin Risk Manag. [Internet]. 2005 (cited 2013 Oct 15); 1(3):189–99. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1661624&tool=pmcentrez&rendertype=abstract.
7. Suggs LS, Raina P, Gafni A, et al. Family physician attitudes about prescribing using a drug formulary. BMC Fam Pract. [Internet]. 2009 (cited 2013 Jul 20); 10:69. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2770461&tool=pmcentrez&rendertype=abstract.
8. Shamima K, Robert S, David S, Bruce P. Physicians’ opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern States. JMCP [Internet]. 2008; 14(8):780–9. http://www.amcp.org/data/jmcp/Oct08-all.pdf.
9. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. Hill S, editor. PLoS Med. [Internet]. Public Library of Science; 2007 (cited 2013 May 31); 4(9):e283. doi:10.1371/journal.pmed.0040283.
10. Von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ [Internet]. 2007; 335(7624): 806–8. Available from: http://www.emgo.nl/kc/Analysis/statements/observationalstudies-lancet-2007.pdf.
11. Shrank WH, Young HN, Ettner SL, et al. Do the incentives in 3-tier pharmaceutical benefit plans operate as intended? Results from a physician leadership survey. Am J Manag Care [Internet]. 2005 (cited 2013 Jul 19); 11(1): 16–22. http://www.ncbi.nlm.nih.gov/pubmed/15697096.
12. Banahan BF, Kolassa E. A physician survey on generic drugs and substitution of critical dose medications. Arch Intern Med. 1997; 157: 2080–8.